Mounjaro monthly weight loss: results, reality and what the price actually covers

You've found a price online — here's what it probably doesn't include

Picture the scene: you've searched, found a headline figure for Mounjaro, and you're trying to work out whether you can afford a month's supply. The number looks straightforward. It rarely is. UK private pricing for Mounjaro is quoted per pen, and each pen covers four weekly injections, so one pen nominally equals one month of treatment. But the dose you start on is not the dose you'll stay on. Tirzepatide begins at 2.5 mg (a tolerability level, essentially, giving your system time to adjust before the therapeutic work begins) and is typically stepped up every four weeks by the prescriber. The pen you buy in month one is almost certainly not the pen you're buying in month four, and the price changes at every step.

Beyond dose, look carefully at what the headline price actually bundles. Some providers list the medicine alone and add consultation fees, prescription charges and delivery on top. Others fold everything in. Our breakdown of what goes into a monthly Mounjaro cost covers this in detail, but the short version is: compare the total outgoing, not the advertised starting figure.

For context on market pricing: Eli Lilly raised Mounjaro's UK list price from 1 September 2025, with the highest-dose pen rising from around £122 to around £330 at list price. Typical private prices since then have ranged roughly £149–£375 per month depending on dose and provider, as widely reported. If you want a clearer sense of what average monthly weight loss on Mounjaro looks like alongside those costs, that context can help you judge whether the investment makes sense at each stage of the schedule. Treat any figure you see as a snapshot, prices move, and lower-dose months look cheaper than higher-dose months simply because of where you are in the schedule.

What a month of progress on Mounjaro actually looks like

Monthly weight loss on Mounjaro is not linear, and the first month is rarely the most dramatic. Most people lose comparatively little in the first four weeks because 2.5 mg is the settling-in dose; the body is adapting, appetite suppression is mild, and the prescriber hasn't yet moved things up. Progress tends to accelerate from months two to six as doses increase and the dual GIP and GLP-1 receptor action builds, tirzepatide is the only weight-loss medicine licensed in the UK that works across both pathways, which is one reason its trial results stand out.

A realistic monthly figure once treatment is established might be 1–2% of body weight for many people, but that is an illustration, not a promise. Factors that shape monthly progress include how closely a reduced-calorie diet is followed, physical activity levels, sleep, stress, and how your body responds to the specific dose. If you want to understand how much weight loss to expect from Mounjaro in a month, our guide walks through what the evidence actually shows for different stages of treatment. The NICE appraisal of tirzepatide, TA1026, notes that if less than 5% of body weight is lost after six months at the highest tolerated dose, continuing treatment should be reviewed, which is one reason clinical oversight across every monthly repeat matters, not just at the start.

Keeping the pen in the same spot each week helps too. A number of people find a consistent routine (say, storing it in the fridge door and dosing on the same evening each week) reduces the chance of a missed or delayed injection during the titration phase when consistency matters most.

The honest position on what nume charges, and why we price the way we do

Cheapest isn't a race we entered. That is a deliberate choice, and it is worth explaining rather than just asserting. At nume, one price covers the consultation, the prescription, the medicine, next-working-day tracked delivery and 7-day aftercare. There are no hidden fees when you reach the checkout, no subscription that renews without your sign-off, and no separate charge to have a prescriber review your repeat. Every order is clinically re-assessed before it goes out. The current treatment pricing is set out on the treatment page, we don't print per-pen figures in articles because they change, and a stale number in body copy misleads more than it helps.

If your priority is finding the single lowest monthly figure, there will be services that quote less. What we'd ask you to weigh alongside the price is what's inside it: identity verification, live weight checks on video, GP notification in line with GPhC guidance, and a real prescriber reading your answers the same day rather than an algorithm triaging them overnight. Our clinical team reviews every consultation personally. That infrastructure has a cost. On a page that explores the full picture of Mounjaro pricing, we set out exactly what our single price includes so the comparison is fair.

Why the cheapest listing isn't the right measure for a prescription medicine

Mounjaro is a prescription-only medicine under UK law. The Human Medicines Regulations require clinical assessment before it can lawfully be supplied. Any seller offering it without that assessment (or appearing to offer significant discounts through social-media channels and unverified platforms) is operating outside the regulated supply chain. The MHRA has made this explicit in its public guidance on GLP-1 medicines safety communications, and enforcement action through 2025 included the seizure of around 20 million doses of illegally traded weight-loss medicines worth approximately £45 million, as well as the raid of a site in Northampton manufacturing counterfeit tirzepatide pens.

Fake pens have been found to contain insulin rather than tirzepatide. The clinical risk is serious. Any seller offering Mounjaro without a prescription, at prices well below the established market range, or through discount codes from unverified sources, is a red flag worth treating seriously. You can verify any online pharmacy on the GPhC pharmacy register, it takes thirty seconds and it is the single most practical safety check available to you. For a prescription medicine, the right question is not which provider quotes the lowest number, but which one can demonstrate the clinical structure that keeps the medicine safe. Spreading treatment costs across a monthly payment plan is a separate question our FAQs cover, and may be worth reading if overall affordability is the concern rather than the per-dose headline figure.